To send content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about sending content to .
To send content items to your Kindle, first ensure email@example.com
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about sending to your Kindle.
Note you can select to send to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Non-traumatic intracranial hemorrhage (ICH) accounts for 10-15% of all strokes, but up to 25% of more severe strokes. This chapter covers the magnetic resonance imaging (MRI) signatures of ICH in all stages, and focuses on the differential diagnosis in hyperacute stroke patients. It deals with subarachnoid hemorrhage (SAH), and discusses the future prospects such as the detection of perihemorrhagic pathological processes, which may contribute to the morbidity of ICH. The appearance of intracranial hemorrhage on MRI depends primarily on the age of the hematoma and the type of MR contrast. Computed tomography (CT) is also the imaging standard of care for the diagnosis of acute subarachnoid hemorrhage. Stroke MRI may be the diagnostic tool of choice not only for patients with subacute and chronic ICH and SAH but also in the initial assessment of patients with hyperacute ischemic or hemorrhagic stroke as well as hyperacute SAH.
Magnetic resonance imaging in clinical stroke
Olav Jansen, Department of Neuroradiology, University of Heidelberg Medical School, Heidelberg, Germany,
Peter D. Schellinger, Department of Neurology, University of Heidelberg Medical School, Heidelberg, Germany
The target for most therapeutic interventions for focal ischemia should be ischemic tissue that can respond to treatment and is not irreversibly injured. Such tissue will be defined as potentially salvageable ischemic tissue and must be distinguished from non-salvageable ischemic tissue that has evolved to a status at which recovery is no longer possible. Characterization of potentially reversible vs. irreversible ischemic tissue is based on the ischemic penumbra hypothesis. Ideally, before any aggressive therapeutic approach (i.e., thrombolysis) is undertaken, four important questions concerning the individual stroke situation should be addressed using only one optimal diagnostic imaging procedure:
Does the patient have acute cerebral ischemia or is another underlying pathology responsible for the stroke symptoms (e.g., intracerebral hemorrhage, tumor)?
Is there already an area of irreversibly damaged ischemic tissue and what is the size of this infarct core?
Is there a tissue of risk (“penumbra”) that can be preserved from damage by therapeutic intervention, and what is the size of this area?
Is the vessel that is responsible for the ischemia still occluded or has there been a pontaneous recanalization?
The ideal imaging modality will be able to address all of these questions within an acceptable amount of time before a specific treatment is begun.
Since the description of early findings in acute experimental ischemic stroke with diffusion-weighted imaging (DWI), it has been predicted that this technique might become an important tool for the identification of very early ischemic injury in patients.
Email your librarian or administrator to recommend adding this to your organisation's collection.